Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Lee NY, Ferris RL, Psyrri A, Haddad RI, Tahara M, Bourhis J, Harrington K, Chang PM, Lin JC, Razaq MA, Teixeira MM, Lövey J, Chamois J, Rueda A, Hu C, Dunn LA, Dvorkin MV, De Beukelaer S, Pavlov D, Thurm H, Cohen E. Lee NY, et al. Among authors: chamois j. Lancet Oncol. 2021 Apr;22(4):450-462. doi: 10.1016/S1470-2045(20)30737-3. Lancet Oncol. 2021. PMID: 33794205 Clinical Trial.
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
Taïeb J, Bouche O, André T, Le Malicot K, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Perrier H, Buecher B, Di Fiore F, Gallois C, Emile JF, Lepage C, Elhajbi F, Tougeron D; SAMCO-PRODIGE 54 Investigators. Taïeb J, et al. JAMA Oncol. 2023 Oct 1;9(10):1356-1363. doi: 10.1001/jamaoncol.2023.2761. JAMA Oncol. 2023. PMID: 37535388 Free PMC article.
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX).
Rinaldi Y, Pointet AL, Khemissa Akouz F, Le Malicot K, Wahiba B, Louafi S, Gratet A, Miglianico L, Laharie H, Bouhier Leporrier K, Thirot Bidault A, Texereau P, Coriat R, Terrebonne E, Gouttebel MC, Malka D, Bachet JB, Lepage C, Taieb J; PRODIGE 37 Investigators/Collaborators. Rinaldi Y, et al. Eur J Cancer. 2020 Sep;136:25-34. doi: 10.1016/j.ejca.2020.05.018. Epub 2020 Jul 2. Eur J Cancer. 2020. PMID: 32623182 Clinical Trial.
[Quality of life for patients treated for head and neck carcinoma].
Maingon P, Créhange G, Bonnetain F, Ligey-Bartolomeu A, Chamois J, Bruchon Y, Romanet P, Truc G. Maingon P, et al. Among authors: chamois j. Cancer Radiother. 2010 Oct;14(6-7):526-9. doi: 10.1016/j.canrad.2010.06.008. Epub 2010 Aug 17. Cancer Radiother. 2010. PMID: 20724192 Review. French.
[Primary liver cancer].
Quivrin M, Mornex F, Enachescu C, Martin E, Ligey-Bartolomeu A, Nouhaud E, Chamois J, Maingon P, Créhange G. Quivrin M, et al. Among authors: chamois j. Cancer Radiother. 2010 Nov;14 Suppl 1:S103-10. doi: 10.1016/S1278-3218(10)70013-5. Cancer Radiother. 2010. PMID: 21129652 French.
[The role of whole brain radiotherapy with hippocampal-sparing].
Truc G, Martin É, Mirjolet C, Chamois J, Petitfils A, Créhange G. Truc G, et al. Among authors: chamois j. Cancer Radiother. 2013 Oct;17(5-6):419-23. doi: 10.1016/j.canrad.2013.06.042. Epub 2013 Sep 3. Cancer Radiother. 2013. PMID: 24011597 French.
20 results